Charles River Laboratories International, Inc. (CRL)

NYSE - Nasdaq Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

244.41

+14.20

(+6.17%)

At close: 04:00PM EDT

244.41

0.00

(0.00%)

After hours:

04:16PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

Commodity Channel Index

View all chart patterns

Performance Outlook

Previous Close	230.21
Open	232.62
Bid	96.14 x 900
Ask	259.99 x 1100
Day's Range	231.69 - 244.41
52 Week Range	217.20 - 460.21
Volume	447,916
Avg. Volume	557,128

Market Cap	12.417B
Beta (5Y Monthly)	1.27
PE Ratio (TTM)	29.79
EPS (TTM)	8.20
Earnings Date	Aug 02, 2022 - Aug 08, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	332.18

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Near Fair Value

6% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for CRL

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Charles River Laboratories Inte
Analyst Report: Charles River Laboratories International, Inc.Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Rating
Fair Value
Economic Moat
20 hours agoMorningstar

All

Insider Monkey
10 Biggest Losers in Gabriel Plotkin’s Melvin Capital Portfolio
In this article, we discuss the 10 biggest losers in Gabriel Plotkin’s Melvin Capital portfolio. If you want to see more holdings that dropped in value, click 5 Biggest Losers in Gabriel Plotkin’s Melvin Capital Portfolio. Reddit investors made it their mission to bludgeon Gabriel Plotkin’s Melvin Capital in their battle with the hedge fund […]
American City Business Journals
Charles River Labs to add 500 more jobs with Ashland expansion project
The contract research organization is adding a 200,000-square-foot expansion to increase capacity for client work and enhance employees' experience.
Simply Wall St.
Charles River Laboratories International, Inc.'s (NYSE:CRL) Intrinsic Value Is Potentially 87% Above Its Share Price
Does the May share price for Charles River Laboratories International, Inc. ( NYSE:CRL ) reflect what it's really...
- An Intrinsic Calculation For PTC Inc. (NASDAQ:PTC) Suggests It's 48% Undervalued
  Simply Wall St.
- Bloomin' Brands, Inc. (NASDAQ:BLMN) Shares Could Be 40% Below Their Intrinsic Value Estimate
  Simply Wall St.